Your CGM sensor tracks it. Omnipod® 5 acts on it.
How it works
Your CGM sensor shares glucose levels with the Pod
Omnipod 5 calculates the required amount of insulin
Insulin delivery adjusts automatically every 5 minutes, day and night.1-2
Omnipod 5 works with the leading CGM sensor brands.
Sensor shown without the necessary adhesive.
“My favourite feature is the way my Omnipod and Sensor communicate directly with each other. They work together to automatically help manage my glucose levels, letting me focus on riding instead of constantly checking my diabetes.”
Brodie
Podder® - Perth WA
Unlock the benefits of automated insulin delivery with your CGM sensor.
CGM sensor + MDI
— Alerts you when you’re high or low
— Multiple daily injections every day
— Complicated mealtime math
CGM sensor + OMNIPOD 5
✓ Alerts you when you’re high or low
✓ No daily insulin injections
✓ Increases, decreases, or pauses insulin delivery every 5 minutes, even while you sleep
✓ Omnipod 5’s SmartBolus Calculator calculates the suggested amount of mealtime insulin
Omnipod is available on the NDSS
Omnipod® 5 is partially subsidised through the NDSS for eligible people with type 1 diabetes, helping to reduce the ongoing cost of Omnipod 5 Pods.
Try it before committing
Order a free Pod Experience Kit* to get a feel for Omnipod in your daily routine. No needles, no commitment.
If you have Type 2 Diabetes please speak with your healthcare professional before you request a call as you might not be considered suitable to use Omnipod®
*The Demo Pod is a needle-free, non-functioning Pod. It will not deliver insulin. The Pod Experience Kit does not include a physical Controller.
1. Brown S. et al. Diabetes Care (2021). Study in 240 people with T1D aged 6 - 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time in Target Glucose range (from CGM) for standard therapy vs Omnipod 5 in adults/adolescents and children = 64.7% vs. 73.9%; 52.5% vs. 68.0%.
2. Sherr JL, et al. Diabetes Care (2022). Study in 80 people with T1D aged 2 - 5.9 yrs involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time in Target Glucose range (from CGM) for standard therapy vs Omnipod 5 = 57.2% vs. 68.1%. Study Funded By Insulet.